GE
GSK Equities Investments
Venture Capital
GlaxoSmithKline's corporate investment vehicle making targeted strategic investments in biotech companies aligned with GSK's pipeline priorities.
1+ investments · 1 portfolio companies
Growth
Biotech
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Jul 2024
- Geographic Focus
- Global
Investment Thesis
Makes targeted strategic investments in biotechs whose science aligns with GSK's R&D priorities, hedging pipeline risk by capturing upside from external innovation alongside partners like SR One.
GSK Equities Investments is a Venture Capital firm. It has made 1 investment in Biotech, including Asceneuron.
Portfolio1
Co-investors7
Sign up to view co-investors
7 co-investors across 7 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×5 · Corporate VC ×2 · 7 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/gsk-equities-investments"><img src="https://indexed.vc/api/badge/investor/gsk-equities-investments" alt="GSK Equities Investments on Indexed.vc" width="260" height="76" /></a>
